Impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer

被引：0
|
作者：
Fowble, B.
Fein, D.A.
Hanlon, A.L.
Eisenberg, B.L.
Hoffman, J.P.
Sigurdson, E.R.
Daly, M.B
Goldstein, L.J.
机构：
来源：
International Journal of Radiation Oncology, Biology, Physics | 1996年 / 35卷 / 04期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The Impact of Exogenous Estrogen Exposure on the Characteristics and Outcome of Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer
    Yariv, Orly
    Mutai, Raz
    Rotem, Ofer
    Tsoref, Daliah
    Korzets, Yasmin
    Moore, Assaf
    Shochat, Tzippy
    Yerushalmi, Rinat
    Goldvaser, Hadar
    ONCOLOGY, 2021, 99 (11) : 713 - 721
  • [32] Early-Stage Estrogen Receptor-Low Positive Breast Cancer - A Unique Entity?
    Vora, Halley
    Kantor, Olga
    Harrison, Beth T.
    Grossmith, Sam
    Mittendorf, Elizabeth A.
    King, Tari A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S313 - S315
  • [33] Clinical analysis of 21-gene recurrence score test in hormone receptor-positive early-stage breast cancer
    Zhu, Lizhe
    Ma, Nan
    Wang, Bin
    Zhou, Can
    Yan, Yu
    Wang, Ke
    He, Jianjun
    Ren, Yu
    ONCOLOGY LETTERS, 2019, 17 (06) : 5469 - 5480
  • [34] The prognostic and predictive role of 21-gene recurrence scores in hormone receptor-positive early-stage breast cancer
    Ahmed, Shahid
    Pati, Sukanya
    Le, Duc
    Haider, Kamal
    Iqbal, Nayyar
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (02) : 144 - 154
  • [35] Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients
    Kyung Lan Ko
    In Suk Shin
    Ji Young You
    So-Youn Jung
    Jungsil Ro
    Eun Sook Lee
    Breast Cancer Research and Treatment, 2013, 142 : 559 - 567
  • [36] Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients
    Ko, Kyung Lan
    Shin, In Suk
    You, Ji Young
    Jung, So-Youn
    Ro, Jungsil
    Lee, Eun Sook
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (03) : 559 - 567
  • [37] Treatment of Estrogen Receptor-Positive Breast Cancer
    Lumachi, F.
    Brunello, A.
    Maruzzo, M.
    Basso, U.
    Basso, S. M. M.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (05) : 596 - 604
  • [38] A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer
    Michael D. Alvarado
    Che Prasad
    Megan Rothney
    Diana B. Cherbavaz
    Amy P. Sing
    Frederick L. Baehner
    Christer Svedman
    Christos J. Markopoulos
    Advances in Therapy, 2015, 32 : 1237 - 1247
  • [39] Identifying Patterns and Barriers in OncotypeDX Recurrence Score Testing in Older Patients With Early-Stage, Estrogen Receptor-Positive Breast Cancer: Implications for Guidance and Reimbursement
    Trapani, Dario
    Jin, Qingchun
    Block, Caroline C.
    Freedman, Rachel A.
    Lin, Nancy U.
    Tarantino, Paolo
    Mittendorf, Elizabeth A.
    King, Tari A.
    Lester, Susan C.
    Brock, Jane E.
    Tayob, Nabihah
    Bunnell, Craig A.
    Tolaney, Sara M.
    Burstein, Harold J.
    JCO ONCOLOGY PRACTICE, 2023, 19 (08) : 560 - +
  • [40] Survival Benefit of Tamoxifen in Estrogen Receptor-Negative and Progesterone Receptor-Positive Low Grade Breast Cancer Patients
    Yang, Li-Heng
    Tseng, Hsin-Shun
    Lin, Che
    Chen, Li-Sheng
    Chen, Shou-Tung
    Kuo, Shou-Jen
    Chen, Dar-Ren
    JOURNAL OF BREAST CANCER, 2012, 15 (03) : 288 - 295
12345